RNAZ·89357L501·US·Common Stock·Healthcare - Biotechnology-Activist
RNAZ (TRANSCODE THERAPEUTICS INC) is held by 4 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($109,690), UBS Group AG ($71,420), WELLS FARGO & COMPANY/MN ($474). Net institutional sentiment: Mixed.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer